Novo Nordisk Foundation
Center for Basic Metabolic Research

Innovation news

CBMR spinout Ousia Pharma raises three-digit million amount to develop their groundbreaking obesity treatment

The spinout builds on a discovery by the Clemmensen Group that NMDA receptor antagonism holds promise for sustained weight loss, which was later published in Nature.

Hansen Group secures DKK 15.6 million to improve the diagnosis of steatotic liver disease

Applying omics technology and machine learning to blood samples could pave the way for earlier detection and precise treatment of steatotic liver – a disease that many people don't know they have. This is the goal of th…

New weight loss drug target burns energy and lowers appetite – without the nausea and vomiting

Scientists have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity.

Professor Thue W. Schwartz wins UCPH Innovation Prize 2023

A founding member of CBMR, Professor Thue W. Schwartz is a pioneering fundamental researcher and co-founder of countless spinouts who has won this year's UCPH Innovation Prize.

Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes

Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie burning and increases insulin sensitivity. The spinout Embark Biotech has now been acquired by Novo Nordisk

"I loved working all the time – from basic research to entrepreneurial work"

Emil Andersen is a PhD candidate at CBMR and is also the co-founder and chief scientific officer of ExSeed Health, which sells kits that allow men to test the quality of their sperm at home.

Research spin outs

Two CBMR Group Leaders join the BioInnovation Institute’s Venture Lab program

Scientists at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) study metabolic health and disease in the hope that their discoveries will lead to new prevention and treatment strategies.

Research translation

CBMR scientists win innovation funding to develop new anti-cancer and obesity drugs

The BioInnovation Institute (BII) has awarded two grants worth DKK 3.5M each to CBMR to develop new drugs based on its basic metabolic research.

Zach Gerhart-Hines awarded DKK 6M Distinguished Innovator grant

Zach Gerhart-Hines awarded DKK 6M Distinguished Innovator grant

Gene-based personalised medicine to treat diabetes

A new project will draw on the genetic information of diabetes patients so that doctors can provide them with personalized treatment.

Science communication

Medical Museion awarded DKK 4,7M for science communication project

CBMR research will reach an even wider audience thanks to a 4,7 million kroner grant from the Novo Nordisk Foundation to support the Medical Museion and their project ‘Microcosmos/Macrocosmos’.

Atul Deshmukh kickstarts group with Future Leaders Award

His group hopes to use mass spectrometry-based proteomics to discover new proteins and peptides for treatment of type 2 diabetes

Medical Museion wins international award

The Medical Museion in Copenhagen, Denmark, has won the prestigious UMAC Award for the museum’s experimental exhibition Mind the Gut.